Acne Clinical Trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of adapalene and benzoyl peroxide gel, 0.3%/2.5% (Actavis Laboratories UT, Inc.) to Epiduo® Forte (adapalene and benzoyl peroxide) gel 0.3%/2.5% (Galderma) in the treatment of Acne Vulgaris
Up to 1000 patients 12 to 40 years of age inclusive will be enrolled to have 870 patients in
the modified intent-to-treat (mITT) population and 579 patients in the per-protocol (PP)
population. The primary inclusion criteria are the presence of ≥ 20 inflammatory lesions
(papules and pustules) and ≥ 25 non-inflammatory lesions (opened and closed comedones) and ≤
2 nodulocystic lesions (i.e., nodules and cysts) on the face and an Investigator's Global
Assessment (IGA) score of 3 or 4.
Eligible patients will be randomized in a 1:1:1 ratio to one of the three treatments (Test,
Reference or Placebo) on Visit 1. Patients will be instructed to apply the first treatment on
the evening of enrollment into the study and then continue to apply once daily for the next
83 days (for a total 84 days). Patients will attend the following scheduled clinic visits:
- Visit 1 - Screening/Baseline: Day 1
- Visit 2 - Interim Visit: Day 28 ± 4
- Visit 3 - Interim Visit: Day 56 ± 4
- Visit 4 - End of Study: Day 85 ± 4 Efficacy evaluations will be based on dermatological
assessments in the clinic. The primary statistical analyses of interest are (1) the
percent change from baseline to Week 12 in the number of inflamed (papules/pustules)
lesions and non-inflamed (open and closed comedones) lesions. In addition, patients will
also be evaluated by the Investigator to determine "Clinical Success" or "Clinical
Failure" at Week 12
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05097157 -
Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions
|
N/A | |
| Completed |
NCT05131373 -
Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris
|
Phase 1 | |
| Completed |
NCT04806594 -
Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.
|
N/A | |
| Recruiting |
NCT03465150 -
Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital
|
||
| Completed |
NCT02250859 -
A Pharmacokinetic Study of Minocycline in Male and Female Volunteers
|
Phase 1 | |
| Completed |
NCT01206348 -
Combination Treatment for Moderate to Severe Acne
|
Phase 4 | |
| Terminated |
NCT01193764 -
Study Assessing the Effect of Chocolate Consumption in Subjects With A History of Acne Vulgaris
|
N/A | |
| Completed |
NCT00725439 -
An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne
|
Phase 2 | |
| Completed |
NCT05640388 -
Assessment of a Cosmetic Product Effect on the Host/Microorganism Relationship in Acneic Subjects
|
||
| Completed |
NCT04873089 -
Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone Skin
|
||
| Recruiting |
NCT05941065 -
Study of Skin Balancing Gel Cream Safety and Influence of Skin Microbiome on Acne Prone Skin
|
N/A | |
| Recruiting |
NCT06120452 -
A Clinical Trial to Evaluate the Effectiveness of an Acne Serum in Improving Facial Acne and Post-Acne Pigmentation
|
N/A | |
| Completed |
NCT04300010 -
Blue Light Therapy of C. Acnes
|
Phase 4 | |
| Recruiting |
NCT06202274 -
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
|
N/A | |
| Completed |
NCT04559022 -
Pilot Study Investigating the Efficacy of Fat Grafting as a Treatment for Male and Female Facial Acne Scarring
|
N/A | |
| Terminated |
NCT02431494 -
Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris
|
N/A | |
| Completed |
NCT05469880 -
Efficacy and Tolerance of Formula 609613 37 in Acneic Patients
|
N/A | |
| Completed |
NCT02944461 -
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
|
Phase 4 | |
| Completed |
NCT01951417 -
Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris
|
Phase 4 | |
| Completed |
NCT01701024 -
Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne
|
Phase 3 |